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Retinal nerve fiber layer atrophy is associated with
physical and cognitive disability in multiple sclerosis
J Toledo1, J Sepulcre1, A Salinas-Alaman2, A García-Layana2, M Murie-Fernandez1,
B Bejarano1 and P Villoslada1
Background Studying axonal loss in the retina is a promising biomarker for multiple sclerosis (MS).
Our aim was to compare optical coherence tomography (OCT) and Heidelberg retinal tomography
(HRT) techniques to measure the thickness of the retinal nerve fiber layer (RNFL) in patients with
MS, and to explore the relationship between changes in the RNFL thickness with physical and
cognitive disability. We studied 52 patients with MS and 18 proportionally matched controls by
performing neurological examination, neuropsychological evaluation using the Brief Repetitive
Battery-Neuropsychology and RNFL thickness measurement using OCT and HRT.
Results We found that both OCT and HRT could define a reduction in the thickness of the RNFL in
patients with MS compared with controls, although both measurements were weakly correlated,
suggesting that they might measure different aspects of the tissue changes in MS. The degree of
RNFL atrophy was correlated with cognitive disability, mainly with the symbol digit modality test
(r = 0.754, P < 0.001). Moreover, temporal quadrant RNFL atrophy measured with OCT was associ-
ated with physical disability.
Conclusion In summary, both OCT and HRT are able to detect thinning of the RNFL, but OCT
seems to be the most sensitive technique to identify changes associated with MS evolution. Multiple
Sclerosis 2008; 14: 906–912. http://msj.sagepub.com
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tomography; physical disability; retinal nerve fiber layer
Introduction
Axonal loss is the most important pathological fac-
tor that contributes to permanent disability in mul-
tiple sclerosis (MS) [1,2]. Assessing axonal loss could
be useful to monitor disease evolution. Although
brain atrophy measured by MRI is strongly depen-
dent on axonal loss, it also reflects neuronal loss,
synaptic pruning, loss of myelin, gliosis, and
changes in water content, each of which contri-
butes differently to permanent disability [3,4].
Recently, the retinal nerve fiber layer (RNFL) has
been studied as a window into brain diseases [5–7],
including MS [8–14]. Indeed, in a previous study we
found that RNFL atrophy was correlated with dis-
ability, disease activity and brain atrophy, both at
the beginning of the disease and in patients that
may or may not display clinical impairment of the
visual pathway [9]. Correlation between RNFL
thickness and brain atrophy on the MRI have been
recently confirmed [15,16], indicating its ability to
detect brain abnormalities. However, we still do not
know if RNFL atrophy is associated with cognitive
impairment as well as the different performance of
the different techniques available for measuring the
RNFL.
Among the different means to assess the RNFL,
optical coherence tomography (OCT), Heidelberg
retinal tomography (HRT) or scanning laser polar-
imetry (GDxVCC) focus on different aspects of the
retina [17], and measurements obtained with these
techniques are not equivalent [18]. OCT measure-
ments are based on interferometry, whereby the
computer analyzes the echo of reflected light from
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a 820 nm laser to obtain a transverse section of the
RNFL at the head of the optic nerve. By contrast,
HRT investigates the optic nerve head primarily
and also the retina. HRT measurements are based
on obtaining different depths of two perpendicular
images of the head of the optic nerve axis with a
670 nm laser, which are subsequently fused to
obtain a three dimensional image. These technical
issues indicate that OCT might better reflect axonal
loss in the RNFL because it most accurately mea-
sures changes in the thickness of the tissue. Alterna-
tively, HRT might provide more information of the
overall volume changes in the thickness of the
RNFL induced by different pathological process,
such as the presence of edema, inflammation,
changes in cell populations and axon density
[12,19,20]. Previous studies of glaucoma and acute
optic neuritis suggested that OCT is more sensitive
to axonal loss and that HRT measurements, mainly
the ratio of the cup to disc area, is more sensitive to
volume changes in the papilla, for example those
induced by inflammation or edema, in addition to
axonal loss [17,20]. However, previous studies in
glaucoma do not provide differences between OCT
and GDxVCC when assessing the RNFL. However, it
is not clear whether HRT measurement of the RNFL
will provide additional information in patients with
MS. Thus, the aim of our study was to compare the
OCT and HRT techniques and to analyze the rela-
tionship between the thickness of the RNFL and
physical or cognitive impairment. This cohort and
data is shared with a previous study analyzing the
association between RNFL, disability and MRI [9].
Methods
Subjects
We studied 52 patients with MS [21] and 18 sex and
age proportionally matched healthy controls (HC).
This cross-sectional study was conducted at the
time of the last evaluation (month 24) in a prospec-
tive cohort used to define the association between
thickness of the RNFL measured by OCT and MS
activities [9]. This analysis was performed at the
time that HRT became available in our centre.
From the 61 patients of the original cohort, we
include all patients in this study except nine
patients: two were lost for follow-up and seven
who did not complete both, OCT and HRT studies.
We found no significant differences in demo-
graphics [age, Expanded Disability Status Scale
(EDSS) or disease subtype] between lost for follow-
up patients and the patients included in the present
study. Patients were recruited by their neurologist
after the study was approved by the Ethical Review
Committee at the University of Navarra and having
obtained written informed consent according to the
Declaration of Helsinki. The inclusion criteria for
patients were having been diagnosed with MS in
the last 10 years, irrespective of the disease subtype.
Use of immunomodulatory drugs were allowed. We
excluded patients with disease duration over
10 years, with severe disability (EDSS >7.0), or with
ophthalmic diseases that might impair or bias the
OCT or HRT measurements (e.g. diabetes, glau-
coma, congenital abnormal optic disc as tilted
nerve, myopia ≥6 diopters and hypermetropia
≥4 diopters). Baseline neurological and ophthalmo-
logic examinations, and OCT and HRT studies were
performed in the same month.
Clinical assessment
Neurological data included number of relapses, dis-
ability progression and the use of immunomodula-
tory therapy recorded in a previous 2-years longitu-
dinal study [9]. Trained staff scored disability using
the EDSS, the MS Severity Scale (MSSS) and the MS
Functional Composite (MSFC). We used the defini-
tion of ‘disability progression’ from Rio et al. [22],
which proposed an increase in the EDSS in 1 point
confirmed in a second visit after 6 months. Cogni-
tive impairment was evaluated by a trained neuro-
psychologist with the Brief Repeatable Battery-
Neuropsychology (BRB-N) as described previously
[23]. Thirty-five patients performed the neuropsy-
chological studies. Cognitive impairment was
defined as a performance 1.5 SD below the control
group in at least two subtests of the BRB-N. Oph-
thalmologic evaluations were performed by two
ophthalmologists blind to the neuropsychology
data and included: visual acuity (VA) using high
contrast Snellen charts, direct ophthalmoscopic
examination following pupil dilation using 1% tro-
picamide, and the measurement of RNFL thickness
by OCT and HRT. Visual impairment was defined as
a best corrected VA ≤20/40. The demographics and
clinical characteristics of patients and controls,
including disease activity in the previous 2 years,
are shown in Table 1.
Optical coherence tomography
The thickness of the RNFL was measured in each
eye using optic coherence tomography with a
StratusOCT (StratusOCT 3000, and OCT 4.0 soft-
ware, Carl Zeiss, Dublin) using the RNFL thickness
3.4 mm scan protocol after pupil dilatation. An
experienced technician who was blind to the results
of the other studies made the measurements. All
scans were obtained three times and averaged. All
scans had a signal strength requirement >7 (maxi-
mum 10) and involved uniform brightness across
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the scan circumference. The average (overall) and
quadrant (temporal, superior, inferior and nasal)
RNFL thickness were obtained in μm. We focused
our analysis in the temporal quadrant based on pre-
vious studies showing a higher reduction of the
RNFL thickness in this quadrant in MS [9,13,14].
Heidelberg retinal tomography
The HRT-3 scanner (Heidelberg Eye Explorer soft-
ware version 1.5.1, Heidelberg Engineering,
GmbH, Heidelberg, Germany) measurements were
obtained by an experimented technician, blind to
the results of the other studies. Three 15° topo-
graphic images were obtained for each eye and a
composite image created from these three images
was used for data analysis. The margin contour
line of the disc to determine the disc area was
drawn at the inner edge of the scleral ring by an
experimented technician, assessed by an ophthal-
mologist in case of doubt. The software calculates
various parameters, including average RNFL thick-
ness, quadrant RNFL thickness, rim-disc area ratio,
cup-disc ratio, and global rim volume. We used the
cut-off point of the average RNFL minus 1.96 SD to
define a pathological RNFL using HRT [24].
Statistical analysis
The normal distribution of all variables was assessed
using the Kolmogorov–Smirnov test. The differ-
ences between groups were assessed with the t-test
for parametric variables or the Mann–Whitney U-
test for nonparametric ones. The correlation
between RNFL thickness (OCT measurements were
normally distributed and the HRT were not nor-
mally distributed), cognitive measures and other
clinical variables was carried out using a bivariate
correlation (Pearson’s or Spearman’s correlation).
In all cases, EDSS was treated as a noncontinuous
variable and analyzed with the Spearman correla-
tion. Analysis was designed a priori for testing aver-
age RNFL and temporal quadrant RNFL thickness
with the clinical variables, based in our previous
study [9]. We excluded eyes with previous optic
neuritis and we choose one eye from every subject
(patient and control) such that the optic neuritis
eyes were avoided. The side (left/right) was chosen
by creating a random sequence. We performed
uncorrected multiple correlations for screening cor-
relation between RNFL and cognitive measures, and
we applied multiple regression analysis in variables
with a P-value <0.005 (adjusted by age and educa-
tion). We used the statistic package SPSS 13.0 for all
analyses (SPSS Inc. Chicago, Illinois, USA).
Results
We examined the capacity of HRT to detect RNFL
atrophy in MS by comparing the RNFL thickness
measured in HC and patients with MS. We found
that in patients with MS the average RNFL thickness
and the thickness of the temporal RNFL quadrants
were lower when compared with HC, as was the
global rim volume (Table 2). However, we found
no differences in the other HRT variables such as
the ratios of the cup to disc or rim to disc area.
HRT identified RNFL atrophy in patients with a pre-
vious history of optic neuritis, either with or with-
out permanent impairment of VA (P = 0.03 and
P = 0.011 respectively), as well as in patients who
had not previously suffered optic neuritis or any
other impairment of the visual pathway
(P = 0.003). By applying the HRT cut-off, obtained
from glaucoma patients [24], we found that while
the average RNFL was below the lower limit of the
95% CI of the normal values in 3% of patients with
MS, none of the controls were below the cut-off.
Finally, the RNFL thickness decreased in patients
of all disease subtypes, including patients at the
beginning of the disease such as CIS patients
(P < 0.05 in all cases). Differences between patients
and controls using OCT are described elsewhere [9].
We were also interested in comparing the results
of OCT and HRT measurements of the RNFL to eval-
uate whether these techniques are equivalent to
monitor patient with MS or whether they provide
complementary information about disease activity.
Table 1 Demographic and clinical variables of patients with MS
and healthy controls
MS
(n = 52)
Controls
(n = 18)
Sex 19 M/33 F 7 M/11 F
Age 37.18 (8.7) 34.9 (8.6)
Disease duration (years) 7.5 (7.2) —
Disease subtype 7 CIS/36 RR/3
SP/3 PP/4 PR
—
Relapse rate in previous 2 years 1.37 (1.49) —
EDSS 2.0 (0–8) —
MSSS 4.5 (1–10) —
MSFC 0.114 (1.06) —
No. eyes with previous optic
neuritis
30 —
No. eyes with visual impairmenta 19 —
The results are expressed as the mean (standard deviation),
except for EDSS and MSSS that it is expressed as the median
and range.
M, Male; F, Female; MS, multiple sclerosis; CIS, clinically isolated
syndrome; RR, relapsing-remitting; SP, secondary-progressive;
PP, primary-progressive; PR, progressive-relapsing; EDSS,
Expanded disability status scale [median (range)]; MSSS, MS
severity scale [median (range)]; MSFC, MS functional composite
[mean (SD)].
aVisual acuity below 0.8 (20/40).
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We found a weak correlation between OCT and
HRT RNFL thickness measures, both average and
by quadrants, both in the overall cohort as well as
in patients with MS (Table 3). Therefore, although
both techniques provide information about the
changes in the RNFL in MS patients, their measures
are not equivalent and they may provide different
information about tissue changes in the RNFL. We
found that RNFL thickness, obtained with OCT cor-
related with physical disability as measured with
the EDSS scale after correcting for multiple compar-
isons (Table 4). Moreover, patients whose disability
had progressed over the previous 2 years displayed a
decrease in the temporal RNFL thickness measured
with OCT (Table 5). However, relapses did not
appear to influence any of the HRT variables in
our cohort, including the cup to disc ratio
(P = 0.139 and P = 0.103 respectively).
It still remains unclear whether RNFL atrophy is
associated with cognitive impairment in MS. In our
cohort, 16 out of 35 patients (45.7%) displayed cog-
nitive impairment (having a performance 1.5 SD
below the control group in at least two subtests of
the BRB-N), while 24 out of 35 (68.6%) performed
1.5 SD below the control group in at least one test.
Indeed, EDSS correlates with the SRT and SDMT
(P < 0.05; data not shown). Patients with cognitive
impairment displayed a trend towards a lower aver-
age RNFL thickness when compared to patients
with no cognitive impairment (P = 0.062). By con-
trast, we found that when measured by OCT, the
average and temporal quadrant RNFL thickness sig-
nificantly correlated with some neuropsychological
test, particularly with the symbol digit modality test
(SDMT) (Table 6). In the multiple regression model
both OCT measures predicted SDMT values after
controlling for age, and number of school years
(temporal quadrant RNFL thickness adjusted
R2 = 0.706; and average RNFL thickness adjusted
R2 = 0.435). After including EDSS and immunomod-
ulatory treatment in a second stepwise model, we
found that correlation between temporal quadrant
RNFL thickness remained significant.
Discussion
The development of new biomarkers for MS is cru-
cial to improve our ability to predict disease evolu-
tion and monitor responses to therapy [4,25]. The
in vivo imaging of the RNFL is a promising strategy
to assess axonal loss in MS [26,27] because the
visual pathway is frequently involved in this dis-
ease, retinal axons lack myelin, and it is a rapid,
reproducible and relatively inexpensive technique.
We and others have found that the thickness of
the RNFL is diminished in patients with MS [8–14]
and optic neuritis [28–31]. Moreover, the presence
of RNFL atrophy is relatively accurate in predicting
disease activity [9]. However, in the present study
the association between RNFL thickness and disease
Table 2 Differences in HRT variables between patients with MS
and healthy controls
HRT MS (N = 52) Controls (N = 18)
Average RNFL 254.5 (100.6)* 275.0 (49.8)
Temporal RNFL 80 (27.2) 86 (49.8)
Temporal inferior RNFL 258.8 (102.3)* 313.8 (78.1)
Temporal superior RNFL 263.8 (79.3) 292.5 (57.2)
Cup-disc area ratio 0.207 (0.137) 0.197 (0.094)
Rim-disc area ratio 0.794 (0.136) 0.804 (0.093)
Global rim volume 0.368 (0.140)* 0.443 (0.113)
The RNFL results are expressed as the mean in μm (standard
deviation) and the results of the global rim volume are expressed
in mm3.
HRT, Heidelberg retinal tomography; RNFL, retinal nerve fiber
layer.
*P < 0.05.
Table 3 Correlation of RNFL thickness measured with OCT or
HRT in MS patients
RNFL OCT HRT r P-value
Average 82.05 (15.7) 236 (76) 0.236 0.003
Temporal 55.42 (14.4) 84 (27) 0.281 0.006
Nasal 68.50 (18.0) 280 (111) 0.175 0.057
Superior 103.85 (21.5) 294 (89) 0.220 0.017
Inferior 99.91 (23.4) 282 (107) 0.191 0.038
Results of the RNFL thickness are expressed as the mean in μm
(SD) for the MS group; and r indicates the spearman correlation
coefficient.
RNFL, retinal nerve fiber layer; HRT, Heidelberg retinal tomogra-
phy; OCT, optic coherence tomography; SD, standard deviation.
Table 4 Correlation between RNFL thickness and physical
disability
EDSS MSFC
r P r P
Average RNFL OCT −0.399 0.010 0.227 0.158
Average RNFL HRT −0.266 0.093 0.147 0.373
Temporal RNFL OCT −0.587 0.00004 0.440 0.004
Temporal RNFL HRT −0.370 0.017 0.048 0.771
Temporal superior RNFL HRT −0.144 0.234 0.158 0.336
Temporal Inferior RNFL HRT −0.235 0.139 0.265 0.103
Cup-disc area ratio HRT 0.241 0.129 −0.255 0.117
Rim-disc area ratio HRT −0.020 0.900 −0.025 0.879
Global rim volume HRT −0.399 0.010 0.227 0.158
The results are shown as the correlation coefficient (r) and the P-
value. Correlation between OCT and MSFC were done using the
Pearson correlation, and the other ones with Spearman correla-
tion. Eyes with previous optic neuritis were excluded from the
analysis.
HRT, Heidelberg retinal tomography; OCT, optic coherence
tomography; RNFL, retinal nerve fiber layer; EDSS, expanded dis-
ability status scale; MSSS, MS Severity Scale; MSFC, MS func-
tional composite.
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activity is weak. This could be due to the fact that
the RNFL is only indirectly assessing the diffuse
axonal loss in the brain, and there is a lesional
threshold and anatomical issue determining the
contribution of axonal loss to permanent disability.
Cognitive impairment in MS is frequent and can
contribute significantly to the reduced quality of
life of patients with MS [23,32]. In this study, we
found significant correlation between RNFL atro-
phy and executive and attention deficits measured
with the SDMT. SDMT is the cognitive test that bet-
ter identify cognitive dysfunction in MS patients
and correlate with disability [23,33]. Thus, our
results suggest that RNFL measurements are able to
identify tissue changes associated with cognitive
impairment. Although RNFL measurements were
introduced in MS at the first time for measuring
the impact of lesions in the anterior pathway (e.g.
optic neuritis), previous results [9,15] indicates that
RNFL thickness provide an indirect estimation of
brain atrophy. The ability of RNFL measurements
to capture the retina counterpart of brain atrophy
[34,35] could explain its correlation with perma-
nent disability and cognitive performance, indepen-
dently of the involvement of the visual pathway in
the functions being tested. However, several limita-
tions might influence these findings. For example,
RNFL thickness is a measure of the anterior visual
pathway and it may be considered to sample the
state of the brain tissue, only indirectly reflecting
overall brain damage. Although the link between
RNFL thickness and cognitive function may be
more dependent of the general distribution of
lesion load, such as more plaques in one place nec-
essarily being associated with more plaques in
others, this fact does not preclude its usefulness as
a biomarker for monitoring brain damage in MS.
This can explain why RNFL thickness measured
with OCT have a good specificity but a low to mod-
erate sensitivity for predicting permanent disability
[9], which is highly dependent on axonal loss.
These facts suggest that this technique is able to
capture small changes in axonal loss, but that the
patched nature of MS might prevent to reflect the
overall brain damage at the retina level. In addition,
our cohort was mainly composed of patients in the
early- to mid-stage of the disease and cognitive
impairment was not severe in the overall cohort,
which might have prevented us from identifying
stronger correlations with cognitive impairment.
Table 5 Association between RNFL thickness and disease activity
Relapse free Disability progressiona
Yes (42.8%) No (57.2%) No (69%) Yes (31%)
Average RNFL OCT 87.50 (13.80) 76.22 (14.05)* 83.46 (13.31) 76.55 (17.58)
Average RNFL HRT 268.6 (118.8) 240.5 (78.96) 272.8 (111.8) 213.1 (53.31)
Temporal RNFL OCT 58.95 (11.52) 54.26 (14.63) 60.97 (12.40) 46.00 (9.05)**
Temporal superior RNFL HRT 284.8 (72.98) 242.9 (81.43) 279.7 (85.4) 228.5 (49.8)*
Rim-disc area ratio HRT 0.791 (0.14) 0.797 (0.14) 0.802 (0.13) 0.775 (0.15)
Cup-disc area ratio HRT 0.211 (0.14) 0.203 (0.14) 0.198 (0.13) 0.228 (0.15)
Global rim volume 0.383 (0.14) 0.353 (0.14) 0.381 (0.15) 0.340 (0.12)
The results of the RNFL are expressed as the mean in μm (standard deviation) and the results of the global rim volume are expressed
in mm3. RNFL values were compared using the Mann–Whitney U-test.
HRT, Heidelberg retinal tomography; OCT, optic coherence tomography; RNFL, retinal nerve fiber layer.
*P < 0.05. **P < 0.01.
aDisability progression: increase in the EDSS in 1 point confirmed in a second visit after 6 months.
Table 6 Correlation between RNFL thickness and cognitive impairment
RNFL Verbal memory Visual memory Executive and
attention
Language fluency
SRT-S SRT-R SRT-D SPART-S SPART-D SDMT PASAT3 WLG-p WLG-s
Average RNFL OCT 0.484* 0.247 0.220 0.428* 0.466* 0.463* 0.546** 0.195 0.214
Average RNFL HRT 0.032 0.226 0.001 0.009 0.056 0.174 0.139 −0.0323 0.045
Temporal RNFL OCT 0.441* 0.272 0.201 0.289 0.189 0.754*** 0.268 0.176 0.141
Temporal superior RNFL HRT 0.113 0.205 0.061 0.174 0.157 0.175 0.250 −0.120 0.121
The results are expressed as the Spearman rank correlation.
SRT-S, Selective Reminding Test Long-Term Storage; SRT-R, Selective Reminding Test Long-Term Retrieval; SRT-D, Selective Remind-
ing Test Delayed Recall; SPART-S, 10/36 Spatial Recall Test; SPART-D, 10/36 Spatial Recall Test Delayed; SDMT, Symbol Digit Modali-
ties Test; PASAT 2–3, Paced Auditory Serial Addition Task 2 and 3 s; WLG-p, Word List Generation-phonetic; WLG-s, Word List
Generation-semantic.
*P < 0.05; **P < 0.005; ***P < 0.001.
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Thus, further studies on larger cohorts and in
patients with progressive disease and more severe
cognitive impairment will help to better define the
potential utility of RNFL measurements to assess
cognitive impairment in MS.
The techniques of OCT and HRT assess structural
RNFL damage in different ways [17]. OCT provides a
direct measure of RNFL thickness using an algo-
rithm capable of locating the anterior and posterior
limits of the RNFL and calculating the RNFL thick-
ness by subtraction. Conversely, HRT is an indirect
measurement of RNFL thickness, extrapolated from
topographic information of RNFL height and the
reference plane. For this reason, HRT is more sensi-
tive to overall volume changes in the tissue. In addi-
tion, because both techniques measured the RNFL
at different location, the absolute number differs,
being for OCT average RNFL in the range of the
100 μm and for HRT average RNFL in the range of
250 μm (0.25 mm). Despite the significant differ-
ence in these techniques to measure RNFL, the
thickness of the RNFL was correlated when mea-
sured by OCT and HRT in glaucomatous eyes
[17,20]. The different technical approaches explain
why previous studies in glaucoma and acute optic
neuritis suggested that OCT is more sensitive to
axonal loss, while HRT measurement is more sensi-
tive to volume changes in the papilla, as produced
by edema and inflammation in addition to axonal
loss [17,20]. Because each technique is more sensi-
tive to different tissue changes, we were interested
in comparing the two techniques to assess whether
they may be associated with different clinical vari-
ables, possibly reflecting the different pathogenic
processes involved in MS (e.g. inflammation and
axon loss). However, the fact that we did not mea-
sured the RNFL during the acute phase of optic neu-
ritis and none of the patients had papillitis at the
time of the ophthalmologic examination might pre-
vent us from detecting the effect of inflammation
in papilla volume changes.
Our study also provides valuable practical infor-
mation when tempting to move RNFL measure-
ments to neurological practice or using it as a surro-
gate marker for clinical trials. First, OCT seems to
offer a better performance than HRT in identifying
tissue changes that correlates with physical disabil-
ity. Second, in addition of measuring the mean
RNFL thickness, the temporal quadrant RNFL thick-
ness measured with OCT seems to be more sensitive
for detecting changes associated with disease activ-
ity. The preferential involvement of the temporal
quadrant of the RNFL in MS have been described
anatomically by the involvement of the maculopa-
pillary bundle [36] and confirmed recently by OCT
[13,14]. However, other studies have shown thin-
ning of all RNFL quadrants using OCT in patients
with optic neuritis or MS. In the study by Fisher, et
al. [8], they found a decrease in all quadrants,
although the decrease was smaller in the nasal
quadrant. In Costello, et al. study [31], they found
a decrease in all quadrants, and Trip, et al. [29]
found that the superior and inferior RNFL quadrant
thicknesses (but not the temporal or nasal quad-
rants) correlated with their corresponding visual
field sectors. However, both cohorts were composed
by patients with more severe ON compared with
Fisher, et al. study and to our study, which might
account for some loss of sensitivity. Third, by study-
ing only eyes without previous optic neuritis we
obtain a better correlate of overall brain damage.
Because the presence of previous optic neuritis
have a strong impact in the RNFL thickness [28–
31], the study of the RNFL in eyes with previous
optic neuritis will reflect more the local effect of
the axonal loss secondary to the optic neuritis
than the widespread axonal loss in the brain with
MS. Further development of standards for the mea-
surement of RNFL, similarly to the development of
MRI standards for MS, as well as new software and
analytical tools might increase the usefulness of this
technique in MS. Moreover, a more detailed study
in patients with MS with different degrees of
inflammation and neurodegeneration (e.g. compar-
ing relapsing and progressive patients with MS),
and prospective studies with patients with acute
optic neuritis, might clarify whether either tech-
nique has sufficient accuracy to distinguish these
components.
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